Multiparametric MRI for prostate cancer diagnosis: current status and future directions

A Stabile, F Giganti, AB Rosenkrantz, SS Taneja… - Nature reviews …, 2020 - nature.com
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy

JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis

B Pradere, R Veeratterapillay… - The Journal of …, 2021 - auajournals.org
Purpose: We identify which nonantibiotic strategies could reduce the risk of infectious
complications following prostate biopsy. Materials and Methods: We performed a literature …

Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta …

E Mazzone, A Stabile, F Pellegrino, G Basile… - European urology …, 2021 - Elsevier
Context The variability of the positive predictive value (PPV) represents a significant factor
affecting the diagnostic performance of multiparametric magnetic resonance imaging …

Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis

V Kasivisvanathan, A Stabile, JB Neves, F Giganti… - European urology, 2019 - Elsevier
Context Magnetic resonance imaging (MRI)-targeted prostate biopsy (MRI-TB) may be an
alternative to systematic biopsy for diagnosing prostate cancer. Objective The primary aims …

Application of electrochemical biosensors for the detection of microRNAs (miRNAs) related to cancer

M Negahdary, L Angnes - Coordination Chemistry Reviews, 2022 - Elsevier
Recently, molecular diagnoses have been demonstrated to be an extraordinary tool for the
diagnosis and prognosis of various cancers. MicroRNAs (miRNAs) as new cancer …

[HTML][HTML] A European model for an organised risk-stratified early detection programme for prostate cancer

H Van Poppel, R Hogenhout, P Albers… - European urology …, 2021 - Elsevier
Context Overdiagnosis as the argument to stop prostate cancer (PCa) screening is less valid
since the introduction of new technologies such as risk calculators (RCs) and magnetic …

Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis

Q Wu, X Tu, C Zhang, J Ye, T Lin, Z Liu… - Prostate Cancer and …, 2024 - nature.com
Purpose Magnetic resonance imaging (MRI) has deeply altered the prostate biopsy strategy
to detect prostate cancer. However, it is still debatable whether the detection rate differs …

Magnetic resonance imaging/ultrasound fusion-guided transperineal versus magnetic resonance imaging/ultrasound fusion-guided transrectal prostate biopsy—a …

BP Rai, C Mayerhofer, BK Somani, P Kallidonis… - European Urology …, 2021 - Elsevier
Context Magnetic resonance imaging (MRI)-targeted biopsies have changed the dogma in
prostate cancer diagnosis. Biopsies can be performed either transrectally (MRI-guided and …

Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study …

UG Falagario, I Jambor, A Lantz, O Ettala… - European urology …, 2021 - Elsevier
Background Previous studies suggested that prostate-specific antigen (PSA) density (PSAd)
combined with magnetic resonance imaging (MRI) may help avoid unnecessary prostate …